Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

More skin lesions in lupus patients may indicate higher disease activity.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Hydroxychloroquine may help delay skin damage in lupus patients.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Hair loss in lupus patients indicates higher disease activity.

Higher IL-17A levels indicate more severe alopecia areata.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Tph cells are linked to the severity of systemic lupus erythematosus.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.